Sage Therapeutics Current Ratio 2013-2020 | SAGE

Sage Therapeutics current ratio from 2013 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Sage Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.90B $0.07B 12.77
2019-12-31 $1.04B $0.11B 9.23
2019-09-30 $1.15B $0.09B 12.67
2019-06-30 $1.26B $0.08B 16.00
2019-03-31 $1.37B $0.07B 20.06
2018-12-31 $0.95B $0.09B 10.98
2018-09-30 $1.04B $0.06B 19.07
2018-06-30 $1.12B $0.05B 23.45
2018-03-31 $1.10B $0.04B 28.92
2017-12-31 $0.53B $0.05B 10.11
2017-09-30 $0.25B $0.05B 4.98
2017-06-30 $0.29B $0.03B 9.02
2017-03-31 $0.35B $0.03B 10.95
2016-12-31 $0.40B $0.04B 11.45
2016-09-30 $0.44B $0.02B 19.47
2016-06-30 $0.27B $0.02B 14.95
2016-03-31 $0.30B $0.02B 18.95
2015-12-31 $0.19B $0.02B 12.31
2015-09-30 $0.21B $0.01B 20.16
2015-06-30 $0.23B $0.01B 20.68
2015-03-31 $0.12B $0.01B 12.80
2014-12-31 $0.13B $0.01B 16.61
2014-09-30 $0.14B $0.01B 27.50
2014-06-30 $0.05B $0.00B 13.11
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2012-12-31 $0.00B $0.00B 2.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.228B $0.007B
SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product candidates include SAGE-547, SAGE-689 and SAGE-217. SAGE Therapeutics, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.114B 36.95
Takeda Pharmaceutical (TAK) Japan $54.448B 9.54
Astellas Pharma (ALPMY) Japan $29.844B 0.00
Eisai (ESALY) Japan $24.126B 20.91
UCB SA (UCBJF) Belgium $23.749B 0.00
Merck (MKGAF) Germany $16.013B 0.00
Grifols, S.A (GRFS) Spain $12.761B 15.86
Catalent (CTLT) United States $12.084B 46.71
Neurocrine Biosciences (NBIX) United States $12.044B 55.66
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.650B 45.99
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.900B 9.44
United Therapeutics (UTHR) United States $5.169B 9.79
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.530B 494.56
Nektar Therapeutics (NKTR) United States $4.276B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.840B 14.12
FibroGen (FGEN) United States $3.722B 0.00
ChemoCentryx (CCXI) United States $3.693B 0.00
PTC Therapeutics (PTCT) United States $3.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.492B 10.24
Pacira BioSciences (PCRX) United States $2.435B 49.83
Cronos Group (CRON) Canada $2.205B 63.20
Corcept Therapeutics (CORT) United States $1.890B 18.74
Xencor (XNCR) United States $1.817B 0.00
USANA Health Sciences (USNA) United States $1.729B 17.74
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.677B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Akebia Therapeutics (AKBA) United States $1.561B 0.00
Indivior (INVVY) United States $1.523B 18.91
Zogenix (ZGNX) United States $1.507B 0.00
Heron Therapeutics (HRTX) United States $1.429B 0.00
Esperion Therapeutics (ESPR) United States $1.410B 0.00
Karyopharm Therapeutics (KPTI) United States $1.402B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.392B 15.00
Theravance Biopharma (TBPH) Cayman Islands $1.364B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.024B 45.70
Tilray (TLRY) Canada $1.000B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.959B 0.00
Endo (ENDP) Ireland $0.790B 1.22
ImmunoGen (IMGN) United States $0.753B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Trillium Therapeutics (TRIL) Canada $0.606B 0.00
VAXART, INC (VXRT) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.591B 0.00
Collegium Pharmaceutical (COLL) United States $0.574B 0.00
Ardelyx (ARDX) United States $0.571B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.511B 12.35
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.464B 18.11
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.408B 0.00
Harpoon Therapeutics (HARP) United States $0.406B 0.00
Ocular Therapeutix (OCUL) United States $0.396B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.389B 0.00
Organogenesis Holdings (ORGO) United States $0.366B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
MEI Pharma (MEIP) United States $0.352B 0.00
Altimmune (ALT) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.300B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
PROFOUND MEDICL (PROF) Canada $0.288B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Taiwan Liposome (TLC) Taiwan $0.241B 0.00
Redhill Biopharma (RDHL) Israel $0.238B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Lannett Co Inc (LCI) United States $0.232B 5.08
KalVista Pharmaceuticals (KALV) United States $0.220B 0.00
Rafael Holdings (RFL) United States $0.204B 0.00
Jounce Therapeutics (JNCE) United States $0.201B 4.80
OptiNose (OPTN) United States $0.189B 0.00
Nivalis Therapeutics (ALPN) United States $0.182B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 23.80
Aquestive Therapeutics (AQST) United States $0.144B 0.00
Otonomy (OTIC) United States $0.130B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.129B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.099B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.096B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Novan (NOVN) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 86.09
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
GTx (ONCT) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.00
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00